Stefanie Schupke
Latest contributions
Antiplatelet strategies for clinical dilemmas
22 May 2025 – From EuroPCR 2025
Dive into the complexities of antiplatelet strategies tailored for challenging clinical scenarios. This session covers antiplatelet therapy in myocardial bridge, bleeding risk reduction via ticagrelor removal before urgent CABG, peri-procedural management for patients on oral anticoagulants undergoing PCI, and the use of cangrelor in out-of-hospital cardiac...
Post PCI anti-thrombotic strategies
15 May 2024 – From EuroPCR 2024
ISAR REACT 5 - Ticagrelor versus prasugrel in patients with acute coronary syndrome
03 Sep 2019
At the ESC Congress 2019 in Paris, Stefanie Schuepke presented the results of the ISAR REACT 5 study. Read this analysis by Francesco Costa and view a short interview with Stefanie Schuepke.
Author
